Q1 2021 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2021-05-20 | ||||||
REV |
Q4 2020 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.380 | -0.820 | -0.4400 | ||||
REV | 860.000K | 0 | -860.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
Ticker | Company | Price | Change | Chg % | Mkt Cap | |
---|---|---|---|---|---|---|
ADCT | ADC Therapeutics | 21.81 | -1.46 | -6.27% | 1.7B |
You can purchase shares of ADC Therapeutics (NYSE: ADCT) through any online brokerage.
Other companies in ADC Therapeutics’s space includes: Macrogenics (NASDAQ:MGNX), Precigen (NASDAQ:PGEN) and Zentalis Pharmaceuticals (NASDAQ:ZNTL).
The latest price target for ADC Therapeutics (NYSE: ADCT) was reported by Morgan Stanley on 2021-03-23. The analyst firm set a price target for 55.00 expecting ADCT to rise to within 12 months (a possible 152.18% upside). 8 analyst firms have reported ratings in the last year.
The stock price for ADC Therapeutics (NYSE: ADCT) is $21.81 last updated Mon Apr 19 2021 19:59:44 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for ADC Therapeutics.
There is no upcoming split for ADC Therapeutics.